Eczema Medical Pharmaceutical 
The Dermatology Digest
FEBRUARY 5, 2024
Children and young adults with eczema or allergies or who have difficulty swallowing may have eosinophilic esophagitis, according to a review study in the Canadian Medical Association Journal (CMAJ). Most patients (75%) have at least 1 atopic (allergic) condition, such as food or environmental allergies, asthma, or eczema.
The Dermatology Digest
MARCH 11, 2024
Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, discusses which ones works best. Just because they are little doesn’t mean we should be afraid to treat them and make their skin disease better,” she stresses.
Associated Skin Care Professionals
AUGUST 14, 2023
Osmosis uses a unique combination of active ingredients that focuses on three important factors: our pharmaceutical-grade delivery system, because most aging occurs deep within the skin; our patented products that create real changes in the skin; and our unique inside-out approach that triggers collagen/elastin and plumps the volume of the face.
First Derm
FEBRUARY 21, 2024
There’s a crucial difference between cosmetic retinol use and medical treatment with retinoids ; the latter is for specific skin conditions under professional supervision. These medical-grade retinoids are often available only by prescription and are used under the close supervision of a healthcare provider.
The Dermatology Digest
MARCH 10, 2024
Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, discusses which ones works best. Just because they are little doesn’t mean we should be afraid to treat them and make their skin disease better,” she stresses.
The Dermatology Digest
MARCH 8, 2024
LEO Pharma recently acquired TMB-001 and other assets from Timber Pharmaceuticals following Timber’s Chapter 11 bankruptcy filing. Mr. Hilberdink: “LEO Pharma is a company that truly aspires to be a leading medical dermatology company that looks at unmet needs in the marketplace, and we see an unmet need in congenital ichthyosis (CI).
The Dermatology Digest
OCTOBER 26, 2024
These findings indicate that upadacitinib may address an unmet medical need in patients with moderate-to-severe AD who do not achieve an adequate response while taking dupilumab,” conclude researchers who were led by Christopher Bunick, MD, PhD, an Associate Professor of Dermatology at Yale University in New Haven, CT.
Expert insights. Personalized for you.
74 
Let's personalize your content